Table 9

 Oligo/amenorrhoeic premenopausal women: negative effect of oral contraceptives on bone mineral density

Study designReferenceNo of patientsOC exposureMeasurement of BMD/bone metabolismResults
OC, Oral contraceptive; BMD, bone mineral density; EE, ethinyl oestradiol; DXA, dual energy x ray absorptiometry.
Case reportZanker et al711 amenorrhoeic athlete (followed between age 24.8 to 36. 9 years)For the first 5 years, used 30 μg EE+150 μg desogestrelLumbar spine, proximal femur DXA9.8% decrease in lumbar spine BMD and 12.1% decrease in proximal femur BMD during 5 years of OC use